← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #164 OF 1,000 MOST-CITED

Buildings not maintained in good state of repair

FDA cited this observation 145 times across 135 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs145
BY FISCAL YEAR
FY202614
FY202521
FY202419
FY202312
FY202214
FY202110
FY20207
FY201915
FY201825
FY20178

How FDA worded it — real examples

Buildings used in the manufacturing of a drug product are not maintained in a good state of repair.

Perrigo New York, Inc. · Bronx, New York · Drugs · 2026-05-08

Buildings used in the processing of a drug product are not maintained in a good state of repair.

Element Materials Technology Boston - Acton Inc. · Acton, Massachusetts · Drugs · 2026-05-04

Buildings used in the holding of a drug product are not maintained in a good state of repair.

Granules Pharmaceuticals Inc. · Chantilly, Virginia · Drugs · 2026-04-03

Buildings used in the manufacturing and processing of a drug product are not maintained in a good state of repair.

Lyne Laboratories, Inc. · Brockton, Massachusetts · Drugs · 2026-03-10

Buildings used in the manufacturing, processing, packing and holding of a drug product are not maintained in a good state of repair.

Gasco Industrial Corp. · Gurabo, Puerto Rico · Drugs · 2026-02-27

Buildings used in the manufacturing, processing, packing and holding of a drug product are not maintained in a good state of repair.

CoreRX Inc. · Clearwater, Florida · Drugs · 2026-02-26

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharma industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →